Translational epigenetics. Epigenetic biomarkers: discovery, validation and clinical applications
2016.01.27 |
Date | Mon 04 Apr |
Time | 14:15 — 16:00 |
Location | The AIAS Auditorium, Buliding 1632, Høegh-Guldbergs Gade 6B, 8000 Aarhus C |
Modern epigenetics is only in its 30s. Yet, this relatively young research field has significantly transformed our understanding of origins of not only cancer but also other diseases. Moreover, epigenetic discoveries have already resulted in new therapies and have a potential to revolutionize routine diagnostics of various diseases. In this seminar, I will discuss my research focusing on the discovery and introduction of epigenetic biomarkers into standard clinical disease management.
Tomasz K. Wojdacz holds a Masters’ degree in biotechnology and a PhD in medicine. He undertook his postdoctoral training at Aarhus University, Karolinska Institute, Sweden, and University of Southampton, UK. Currently, he is an Associate Professor and an AIAS fellow. He is mainly interested in translational epigenetics with focus on clinical applications of epigenetic biomarkers. He is also actively involved in initiatives aiming at promoting entrepreneurship in academic research.
Tomasz Wojdacz's project at AIAS.
The AIAS Fellows' Seminar is a session of seminars held by the AIAS fellow or by other speakers proposed by the fellows. In each seminar, one fellow will present and discuss his/her current research and research project, closing off with a question and discussion session.
All seminars are held in English and open to the public. Registration to the seminar is not necessary. Read more about the AIAS Fellows' Seminar here.